Nevro Corp. (NVRO) News

Nevro Corp. (NVRO): $45.97

-0.41 (-0.88%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Filter NVRO News Items

NVRO News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

NVRO News Highlights

  • NVRO's 30 day story count now stands at 11.
  • Over the past 24 days, the trend for NVRO's stories per day has been choppy and unclear. It has oscillated between 1 and 3.
  • The most mentioned tickers in articles about NVRO are SCS, DECK and HOLX.

Latest NVRO News From Around the Web

Below are the latest news stories about Nevro Corp that investors may wish to consider to help them evaluate NVRO as an investment opportunity.

Nevro Corp. 2021 Q4 - Results - Earnings Call Presentation

The following slide deck was published by Nevro Corp. in conjunction with their 2021 Q4 earnings call....

SA Transcripts on Seeking Alpha | February 24, 2022

Nevro Corp.'s (NVRO) CEO Keith Grossman On Q4 2021 Results - Earnings Call Transcript

Nevro Corp. (NVRO) Q4 2021 Earnings Conference Call February 23, 2022 4:30 P.M. ET Company Participants Julie Dewey - Corporate Communications and Investor Relations Officer Keith Grossman - Chairman, Chief Executive Officer and President Rod MacLeod - Chief Financial Officer Conference Call Participants Chris Pasquale - Guggenheim Adam Maeder -...

SA Transcripts on Seeking Alpha | February 24, 2022

Nevro's (NVRO) Q4 Earnings in Line, Revenues Beat Estimates

Nevro's (NVRO) worldwide revenues fall on a year-over-year basis in Q4 due to soft geographical performances.

Yahoo | February 24, 2022

Nevro (NVRO) Reports Q4 Loss, Tops Revenue Estimates

Nevro (NVRO) delivered earnings and revenue surprises of 0% and 0.26%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | February 23, 2022

Nevro Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides First Quarter and Full-Year 2022 Guidance

Nevro Corp. (NYSE: NVRO), delivering comprehensive, life-changing solutions for the treatment of chronic pain, today reported its financial results for the fourth quarter and full-year ended December 31, 2021 and provided guidance for the first quarter and full-year of 2022.

Yahoo | February 23, 2022

Nevro to Participate in Wells Fargo 2022 MedTech R&D Spotlight Call Series

Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, today announced that D. Keith Grossman, Nevro's Chairman, CEO and President, Rod MacLeod, Chief Financial Officer, and Dr. David Caraway, Chief Medical Officer, will participate in the Wells Fargo 2022 MedTech R&D Spotlight Call Series on Friday, March 4, 2022 at 10:00 am Eastern Time.

Yahoo | February 18, 2022

Nevro Announces Publication of 12-Month Data from SENZA-NSRBP Randomized Controlled Trial in Journal of Neurosurgery: Spine

Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, today announced 12-month data from the SENZA-NSRBP randomized controlled trial (RCT) was published online in Journal of Neurosurgery: Spine.1 These data show that high-frequency 10 kHz spinal cord stimulation (SCS) therapy results in profound improvement in non-surgical refractory back pain (NSRBP) patients compared to Conventional Medical Managem

Yahoo | February 11, 2022

5 things to know about this cancer-focused biopharma’s recent IPO

The offering, set to close Tuesday, comes less than a year after the company raised a whopping $115 million in Series C funding.

Yahoo | February 8, 2022

Here's Why You Should Retain Nevro (NVRO) Stock For Now

Investors continue to be optimistic about Nevro (NVRO) owing to its strength in the global SCS market.

Yahoo | February 8, 2022

Hologic (HOLX) Q1 Earnings and Revenues Surpass Estimates

Hologic (HOLX) delivered earnings and revenue surprises of 80.83% and 31.43%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | February 2, 2022


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.4334 seconds.